Opinion: As a rule, rape exceptions for abortion don’t work
A year before the Supreme Court overturned Roe v. Wade in 2022, Texas implemented Senate…
Category: policy
STAT+: Nuclear Regulatory Commission advisers beset by conflicts of interest, report finds
The oversight division of a U.S. government agency tasked with ensuring the safe use of…
How resurrecting extinct species might impact medicine
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Watch: Medicare billing forms are running out of space for growing health care prices
WASHINGTON — Health care costs are getting so high that prices are literally running off…
STAT+: Critics say U.K. decision on ALS drug could have ‘chilling effect’ on access to new genetic medicines
LONDON — Neurologists and patient advocates are up in arms over a policy decision by…
GLP-1 generics would be dramatically cheaper than U.S. price of Ozempic, study shows, but still profitable
Diabetes drugs are too expensive in the U.S., and insulin is infamously six to 13…
How GLP-1’s moved from research labs to national TV
Today is the inaugural publishing day for Adam’s Biotech Scorecard — a subscriber-only newsletter offering…
.jpg)
Who can sue the FDA? Answering Justice Alito’s question from the mifepristone arguments
WASHINGTON — Supreme Court Justice Samuel Alito had a clear question at Tuesday’s arguments over…
The Food is Medicine movement originators are trying to standardize medically tailored meals
WASHINGTON — Food corporations, grocery stores, and even tech companies are claiming they are a…
STAT+: Some nonprofit hospitals spend less on charity care than they receive in tax breaks, new analysis shows
A new study of hospitals’ charity care spending suggests nonprofit hospitals really aren’t that different…
Supreme Court mifepristone arguments focus on physicians’ right to sue, not FDA judgment
WASHINGTON — Supreme Court justices on Tuesday seemed to question physician’s right to sue the…
How expanded methadone access helped Switzerland defuse its drug crisis
ZURICH — The lobby of this addiction clinic is unremarkable, really, except for the network…
SCOTUS’ abortion pill mifepristone case is really about the FDA
WASHINGTON — The Supreme Court on Tuesday will hear opening arguments in an abortion medication…
Opinion: Methadone treatment has been reformed for the better. States shouldn’t go back to the old ways
Since the Food and Drug Administration approved methadone for treating opioid use disorder in 1972,…
STAT+: Medicare expected to negotiate obesity drug prices soon, new analysis predicts
WASHINGTON — Medicare will likely choose the obesity drug semaglutide for price negotiation “within the…
The U.S. banned asbestos, but its health impact will still be felt for decades
A new rule announced by the Environmental Protection Agency this week puts an end to…
Supreme Court questions restricting government efforts to limit Covid-19 misinformation
WASHINGTON — Most of the Supreme Court’s justices on Monday seemed to question states’ arguments that…
Inside a push to create an NIH office for post-infection chronic illness
When the White House released President Biden’s 2025 budget requests this week, funding for biomedical…
Opinion: Prescription for resilience: Health care needs financial sector-inspired regulation
In the early days after it was hit by a cyberattack on Feb. 21, Change…
STAT+: Medicare couldn’t cover Wegovy for weight loss. But now that it’s also a heart drug, the door is open
WASHINGTON — Novo Nordisk’s newly won permission to market the heart benefits of its obesity drug…
STAT+: Q&A: Amid AI frenzy in medicine, a federal regulator’s quest to create safeguards
Micky Tripathi is equal parts excited — and deeply concerned — about the technological change…
STAT+: BIO severs ties with WuXi in the face of U.S. government concerns over China
WASHINGTON — The Biotechnology Innovation Organization, an industry trade group, is cutting ties with Chinese…
STAT+: Pharma loses a key battle over a state law concerning 340B pharmacies
In a setback to the pharmaceutical industry, a U.S. appeals court has upheld an Arkansas…
Rigid rules at methadone clinics are jeopardizing patients’ path to recovery from opioid addiction
DETROIT — Every morning, Rebecca Smith, nursing a surgically repaired knee, carefully walks down the…
STAT+: New methadone rules are about to take effect. Here are 6 ways treatment could shift
The federal government is reforming methadone care for the first time in over two decades….
STAT+: U.K. researchers warn about biases in medical devices, health care algorithms
LONDON — Regulators, clinicians, and health care algorithm developers need to take additional steps to…
Eli Lilly’s anti-vanity ad campaign for Oscars
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Biden calls for election wake-up call on abortion rights — but new upheavals are fast approaching
WASHINGTON — President Biden started his sprawling national address Thursday night with a warning to…
In his State of the Union, Biden takes clear aim at ‘Big Pharma’
WASHINGTON — Often, a president’s State of the Union address is a staid affair, with…
STAT+: Pharma giants, government spar in court over Medicare drug price negotiation
TRENTON, N.J. — Pharma industry giants including Bristol Myers Squibb, Johnson and Johnson, Novartis, and…
STAT+: Nursing home owners can hide nearly two-thirds of their profits, new study shows
A new study shows that some nursing homes are shunting the majority of their profits…
Biden to propose expanding Medicare drug price negotiation in State of the Union
WASHINGTON — President Biden wants to more than double the size of Medicare’s new drug…
STAT+: Senate panel advances bill to ban some Chinese biotechs, with Sen. Paul taking up industry’s cause
WASHINGTON — A Senate panel today passed a bill aimed at preventing certain Chinese companies…
STAT+: Republicans consider a new attack on Biden ‘march-in’ plan for lower drug prices
WASHINGTON — Republicans in Congress might try to use a technical maneuver to block the…
How the U.S. is sabotaging its best tools to prevent deaths in the opioid epidemic
The opioid overdose epidemic has burned through the U.S. for nearly 30 years. Yet for…
STAT+: White House is told the big three PBMs are ‘everything wrong with this industry’
As part of its battle to blunt the growing cost of medicines, the White House…
STAT+: White House touts incremental step in Medicare drug price negotiation: counteroffers
WASHINGTON — The White House on Monday ballyhooed a routine step in Medicare’s new program…
STAT+: Massachusetts lawmakers consider $1 billion proposal to bolster region’s life science leadership
Next stop: Beacon Hill. Governor Maura Healey’s long-awaited plan to double down on state funding…
STAT+: Explaining Change Healthcare and the gravity of its cyberattack
The cyberattack on Change Healthcare has fractured the country’s health care payment infrastructure. But it…
STAT+: Federal judge rules against AstraZeneca in lawsuit challenging Medicare drug price negotiation
WASHINGTON — A federal judge in Delaware on Friday ruled against AstraZeneca in a case…
STAT+: What does America’s crackdown on Chinese firms mean for the U.S. biotech sector?
WASHINGTON — The federal government increasingly is scrutinizing Chinese businesses and their interactions with American…
House looks to weaken Medicare negotiation
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Why won’t Medicare deliver food to sick seniors, if it could get them healthy?
WASHINGTON – Some twelve percent of traditional Medicare beneficiaries have heart failure. Roughly a quarter…
STAT+: FTC says pharmacy benefit managers are stonewalling requests for information
A much-anticipated inquiry by U.S. antitrust regulators into pharmaceutical industry middlemen has been stymied because…
STAT+: Experts say scale of Change cyberattack shows risk of centralized claims processing
Change Healthcare’s recent cyberattack has hospitals, doctors’ offices, and pharmacies across the country reeling as…
STAT+: Congress ditches site-neutral hospital pay policy
WASHINGTON — Congress will not move forward with a controversial policy to equalize certain Medicare…
STAT+: Congress punts on PBM reform efforts
WASHINGTON — Congress has abandoned its attempt to reform how pharmacy middlemen operate in an…
STAT+: Amgen’s rheumatoid arthritis drug Enbrel targeted for first-in-the-nation price limit in Colorado
WASHINGTON — Colorado is pioneering a new way for states to crack down on prescription…
What do CEOs owe the world?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: San Diego biotech Neurocrine Biosciences joins PhRMA
WASHINGTON — Neurocrine Biosciences, a biotech company based in California, has joined the drug lobbying…